Novel Multimodal Management of Post-Partum Synchronous Metastatic Pulmonary EBV-Associated Lymphoepithelioma-Like Carcinoma (LELC)-A Case Report.
EBV-associated lymphoepithelioma-like lung carcinoma
LELC
chemoimmunotherapy
lung cancer in pregnancy
multi-site radiation therapy
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
09 Nov 2021
09 Nov 2021
Historique:
received:
08
10
2021
revised:
01
11
2021
accepted:
05
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Primary Epstein-Barr-Virus (EBV)-associated pulmonary lymphoepithelioma-like carcinoma (LELC) is an aggressive rare cancer. Higher incidences have been observed in Asian sub-populations. Multimodal treatment paradigms have emerged as promising novel strategies in the management of advanced NSCLC. In this report, we describe the case of a 34-year-old female patient of Asian origin with a post-partum initial diagnosis of pulmonary LELC. Multimodal treatment with chemoimmunotherapy and hypofractionated irradiation to the primary tumour and main metastatic sites led to a favourable response demonstrating that radiotherapy may potentially augment anti-tumour immunity. To the best of our knowledge, this is the first case report on this novel therapy strategy of multi-site hypofractionated radiotherapy and chemoimmunotherapy for metastatic pulmonary EBV-associated LELC.
Identifiants
pubmed: 34829420
pii: diagnostics11112072
doi: 10.3390/diagnostics11112072
pmc: PMC8624618
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Am J Surg Pathol. 2021 Nov 1;45(11):1476-1486
pubmed: 33927156
Onco Targets Ther. 2020 May 11;13:3921-3929
pubmed: 32494151
Front Oncol. 2021 Apr 26;11:626566
pubmed: 33981599
Med Oncol. 2020 Mar 7;37(3):20
pubmed: 32146584
Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):225-226
pubmed: 32414625
Cancer Res. 2005 Jul 15;65(14):6450-8
pubmed: 16024650
Int J Mol Sci. 2017 Aug 05;18(8):
pubmed: 28783064
Steroids. 2011 Aug;76(9):910-20
pubmed: 21600232
Lancet Oncol. 2021 Feb;22(2):198-211
pubmed: 33476593
Clin Lung Cancer. 2019 May;20(3):e393-e401
pubmed: 30691964
J Natl Compr Canc Netw. 2021 Mar 02;19(3):254-266
pubmed: 33668021
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3975-3989
pubmed: 33760957
Eur J Nucl Med Mol Imaging. 2021 Oct 19;:
pubmed: 34664091
Nat Rev Clin Oncol. 2019 Feb;16(2):123-135
pubmed: 30401936
Onco Targets Ther. 2021 Feb 16;14:1073-1081
pubmed: 33628032